Jens Bager
Industrial Partner @ Impilo
Copenhagen, Denmark
Jens Bager is a Series B investor at Impilo in Copenhagen focused on Biopharma and Health Care. Jens Bager - Chairman and Investor @ Scantox
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Jens Bager invests in
Stages Jens Bager invests in
Countries Jens Bager invests in
Investment Focus
Industry
- Biopharma 1 (50%)
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Health Diagnostics 1 (50%)
Stage
- Series B 1 (50%)
- Series C 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DBV Technologies
|
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapythat aims to activate the immune system of patients through the skin. | $25.5M / Series C / Jan 05, 2011 | |
|
DBV Technologies
|
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving their commitment to the advancement of treatments in this field, they are investigating a potential new class of immunotherapythat aims to activate the immune system of patients through the skin. | $6.6M / Series B / Jan 22, 2009 |
Co-Investors
About Impilo
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which theyoperate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.
Impilo Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Jesper Eliasson
Partner & CFO
|
|||
|
Jens Bager
Industrial Partner
|
|||
Magnus Edlund
Partner
|
|||
Martin Fagerlund
Partner & COO
|
|||
Sören Mellstig
Co-founder
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Jens Bager invest in?
Jens Bager invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series B and Series C stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Jens Bager last invest?
The most recent investment recorded for Jens Bager closed in Jan 2011. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
